Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jörg G.D Birkmayer"'
Publikováno v:
Journal of Environmental Pathology, Toxicology and Oncology. 23:179-194
The objective of the study was to determine both the toxicity of the stabilized orally absorbable form of nicotinamide adenine dinucleotide (NADH) (ENADA) and the maximum tolerated intravenous dose (MTD) of betaNADH (the reduced form of NADH) in beag
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1573:177-182
A new assay allowing quantitation of extracellular NADH metabolisation by intact blood cells was compared with the intracellular ATP/ADP ratio of these cells. The sensitivity, reproducibility and NADH specificity of this assay were determined. The di
Autor:
Reinhard Möller, Jörg G.D. Birkmayer, Erwin Tafeit, Karoline Vrecko, Gilbert Reibnegger, Danijela Storga, Renate Horejsi
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1361(1):59-65
Treatment of Parkinson patients with l -DOPA (3,4-dihydroxy- l -phenylalanine) leads to endproduct inhibition of tyrosine hydroxylase, the key enzyme in dopamine biosynthesis and the enzyme needing tetrahydrobiopterin and iron as cofactors. To overco
Autor:
Jörg G.D. Birkmayer, Markus Wögerbauer, Meinrad Lindschinger, Karl Nadlinger, Norbert Adelwöhrer, Karin Holweg, Karl-Heinz Smolle, Willibald Wonisch
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 42
When reactive oxygen species attack biological structures, peroxides, which are short-lived oxidative intermediates, are generated. We evaluated the potential of two different, commercially available peroxide activity assays (Pox-Act and d-ROMS) to s
Publikováno v:
Neuroimmunomodulation. 9(4)
Objective: Recently, therapy with nicotinamide adenine dinucleotide (NADH) revealed positive effects on neurodegenerative disorders associated with inflammation of the CNS, such as Parkinson’s disease or Alzheimer’s disease. Pathophysiologically,
Publikováno v:
Neuroscience letters. 203(1)
The catecholamines dopamine (DA), noradrenaline (NA) and adrenaline (A), their aminoacid precursors tyrosine (Tyr), L-3,4-dihydroxyphenylalanine (L-DOPA), two of their metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxy phenyl
Autor:
Jörg G.D. Birkmayer
Sevenhundredandtwelve patients with a known history of breast or gastro-intestinal cancer in the stage of post-primary treatment have been followed up on the basis of three tumor markers: the Tissuepolypeptideantigen TPA, the carcinoembryonic antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eb93e8062150c42813c57bf2f1ffa2e
https://doi.org/10.1016/b978-0-08-031739-7.50184-1
https://doi.org/10.1016/b978-0-08-031739-7.50184-1